Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1075 of 1,261

  1. US 7279159

    VEGF inhibitor polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  2. US 7279163

    Water-in-oil emulsion vaccines

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  3. US 7279294

    Tumor markers in ovarian cancer

    The United States of America as represented by the Secretary, Dept. of Health and Human Services, NIH · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  4. US 7279306

    Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof

    The Regents of the University of Colorado · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  5. US 7279326

    Composition for delivery of a mitochondrial genome to a cell

    Northwestern University · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  6. US 7279322

    Electrospraying apparatus and method for coating particles

    Regents of the University of Minnesota · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  7. US 7279466

    Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

    THE ARIZONA BOARD OF REGENTS · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  8. US 7279571

    Methods of preparing pimecrolimus

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  9. US 7279476

    Pyrazole-derived kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  10. US 7279320

    Curlicue vaccine strain of Bacillus anthracis

    United States Army as Represented by the Secretary of the Army · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  11. US 7279469

    Diaminotriazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  12. US 7276527

    5-pyridyl-1,3-azole compounds, process for producing the same and use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted

  13. US 7276352

    Induction of β cell differentiation in human cells by stimulation of the GLP-1 receptor

    The Regents of the University of California · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted

  14. US 7276643

    Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents

    The Regents of the University of California · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted

  15. US 7276502

    Thiazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted

  16. US 7276348

    Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted

  17. US 7276227

    Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted

  18. US 7276629

    Hydrogenation of imine intermediates of sertraline with catalysts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted

  19. US 7273857

    Benzimidazolidinone derivatives as muscarinic agents

    ACADIA Pharmaceuticals Inc. · Granted Sep 25, 2007 · Expires Sep 20, 2027

    granted

  20. US 7273885

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 25, 2007 · Expires Sep 20, 2027

    granted

  21. US 7273923

    Zinc finger proteins for DNA binding and gene regulation in plants

    Sangamo Biosciences, Inc. · Granted Sep 25, 2007 · Expires Sep 20, 2027

    granted

  22. US 7273853

    6-11 bicyclic ketolide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2007 · Expires Sep 20, 2027

    granted

  23. US 7273851

    Tri-peptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2007 · Expires Sep 20, 2027

    granted

  24. US 7273713

    Methods of modulating mitochondrial NAD-dependent deacetylase

    The Regents of the University of California · Granted Sep 25, 2007 · Expires Sep 20, 2027

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.